ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • Live CE Webinar: Precision in Practice: Unlocking the Potential of Beta-Lactam Antibiotics through Optimal Therapeutic Drug Monitoring

Live CE Webinar: Precision in Practice: Unlocking the Potential of Beta-Lactam Antibiotics through Optimal Therapeutic Drug Monitoring

  • 26 Mar 2024
  • 1:00 PM - 2:00 PM (EDT)

Tuesday, March 26, 2024
12:00 pm – 1:00 pm CT / 1:00 pm – 2:00 pm ET

Register 

Therapeutic drug monitoring (TDM) of beta-lactam antibiotics is recommended to address variability in exposure, with the goal to optimize clinical outcomes and minimize toxicity. Given the widespread use of beta-lactam antibiotics for many infectious diseases and the critical need for optimized dosing in specific patient populations, continuing education on this topic is essential to improve patient outcomes, reduce toxicity, and promote antimicrobial stewardship.

This webinar aims to review the fundamentals of beta-lactam TDM and to provide pharmacists and other healthcare providers with the tools necessary to implement beta-lactam TDM. This activity will incorporate interactive elements via audience polling with an opportunity for Q&A at the end.

Target Audience:

This activity was planned to meet the educational needs of infectious diseases pharmacists and other healthcare providers who prescribe and dose beta-lactam antibiotics.

Learning Objectives:

  • Correlate clinical outcomes to established pharmacokinetic/ pharmacodynamic targets for individual beta lactam antibiotics.
  • Identify patient groups and clinical scenarios that may benefit from beta-lactam therapeutic drug monitoring (TDM).
  • Summarize the current limitations of beta-lactam TDM.
  • Outline strategies to incorporate beta lactam TDM into clinical practice.

Faculty:

Andrew Fratoni PharmD
Associate Director, Clinical and Laboratory Studies
Center for Anti-Infective Research and Development
Hartford Hospital
Hartford, CT

Accreditation:

Pharmacist

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0672-0000-24-008-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
Activity Fee: SIDP Member: Free / Non-Member: $10

To receive CE credit, participants must attend the webinar, complete online a post-test with a passing score of 70% or greater and an activity evaluation. Proof of completion will be submitted to NABP CPE Monitor.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.

Funding:

This activity is provided by SIDP. No external funding was received for this activity.

Disclosures:

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:

  • Dr. Fratoni has no financial relationship with an ineligible company to disclose.
  • SIDP planners, staff and other individuals who are in a position to control the content of this CE activity have no relevant financial relationships with an ineligible company to disclose.

Disclaimer:

Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.

The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.


Register 


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software